Tianyi Lu

机构：Chinese Academy of Sciences, Sichuan University, Beijing Institute of Genomics, Moderna Therapeutics (United States), Shengli Oilfield Central Hospital, China National Electric Apparatus Research Institute (China), Shanghai Center For Bioinformation Technology, University of Chinese Academy of Sciences · ORCID：0000-0001-8410-9051

发表论文 74 篇 · 总被引 1103 次 · h-index 17

代表论文

Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United States (2024 · Open Forum Infectious Diseases · 被引 26)
Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States (2024 · Infectious Diseases and Therapy · 被引 18)
Leveraging artificial intelligence for enhanced risk management in financial services: Current applications and future prospects (2024 · Engineering Science & Technology Journal · 被引 17)
Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysis (2024 · medRxiv · 被引 9)
Basic Transcription Factor 3 Like 4 Enhances Malignant Phenotypes through Modulating Tumor Cell Function and Immune Microenvironment in Glioma (2024 · American Journal Of Pathology · 被引 9)
Incidence and Burden of Respiratory Syncytial Virus-Associated Hospitalizations Among People 65 and Older in France: A National Hospital Database Study (2025 · Open Forum Infectious Diseases · 被引 7)